Form Bio is a dynamic startup, established in 2022, making strides in the Biotechnology, Data Analytics, and Information Technology sectors. As a leading provider of AI-powered solutions for genetic medicine and genome engineering, the company is at the forefront of integrating cutting-edge technology with life sciences.
Though headquartered location details are currently unavailable, Form Bio secured a significant $30.00M investment on 01 September 2022 through a Corporate Spinout. This strategic funding round was supported by reputable investors, including Colossal Biosciences, Jazz Venture Partners, and Thomas Tull.
The company's innovative approach positions it as a promising player in the biotech landscape, rapidly advancing solutions for genetic and genomic challenges. With strong investor backing and a focus on leveraging AI for healthcare advancements, Form Bio presents a compelling opportunity for stakeholders interested in the intersection of technology and medicine.
